This report was recently updated on April 18 2024 with the latest and most recent
market numbers
Global Immunofluorescence Assay Market Size, Trends, and Analysis - Forecasts To 2026 By Product (Antibodies, Reagents, Kits, Instruments, Consumables, and Accessories), By Type (Indirect Immunofluorescence, Direct Immunofluorescence) By Disease (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Hospitals & Diagnostics Centers), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Immunofluorescence Assay (IFA) is also known as a usualvirologic technique used to identify the existence of antibodies in infected cells. Antibodies act as a guard and defender against any foreign invaders and signals the immune system to act on them. A higher rate of antibodies requires a healthier immune system. Therefore the demand for immunofluorescence assay is indirectly related to the rate of diseases. Specialized kits and instruments help ease put the process of testing and provide a degree of convenience to its end users. Higher the rate of ill people, the more the demand for immunofluorescence assay. The products are widely used in different medical facilities such as hospitals, pharmaceutical & bio companies, academic and research institutes, and medical research organizationsamong others.
During COVID 19 pandemic the need for immunofluorescence assay increased immensely globally, as they were used to detect the corona antigens. This along with their hiked-up usage for testing of COVID within patients and potential patients helped in skyrocketing the demand for immunofluorescence assay globally during the forecast duration. As more and more companies indulge in vaccine testing stages, moving ahead with human subject experiments requires the usage of immunofluorescence assay for better results in vaccine formation.
The market for Immunofluorescence Assay is bifurcated into Antibodies, Reagents, Kits, Instruments and Consumables, and Accessories according to product analysis. The Antibodies hold the highest market share according to the 2020 sales. This was due to the increase in chronic illness as immunofluorescence assay help in detecting antibodies and antigens. Also during the pandemic, the antibodies testing hiked up the need for immunofluorescence assay. With the pandemic hitting the world at the start of 2020, the use of Kits started to increase, upsurging its revenue share. This is contributed due to their ease of usage, flexibility to the user, and convenience in traveling. Due to the rise in cases during the boom period of the coronavirus cases, and the shortage of medical facilities, many patients were tested and treated in their homes and other quarantine confinement. During this duration, the usage of kits and instruments increased by varied medical workers.
The product market for immunofluorescence assay is bifurcated into two, Indirect Immonoflurescence and Direct Immonoflurescence according to type analysis. During the forecasted duration, indirect immunofluorescence assay accounted for the fastest growth in terms of revenue. This is because they are easy to use, inexpensive, flexible, sensitive, have a better amplification amongst all types of immunofluorescence. They are also easier to transport and export-import between countries. On the other hand, direct immunofluorescence is one antibody injected targeted towards a certain pointer. On the other hand indirectimmunofluorescence, uses two antibodies. Depending on the usage, both, are demanded in varied fields.
The immunofluorescence assay is used to treat different diseases such as Autoimmune Disease, Cancer, Infectious Disease, and Cardiovascular diseases among others. According to the disease analysis, cancer accounted for the largest market share, this is contributed due to an increase in chronic patients worldwide, alsoimmunofluorescence is being used to test cancer cells in bodies. Immunofluorescence was already being used to test antibodies and antigens in patients for infectious diseases and cardiovascular diseases. During the coronavirus pandemic, the autoimmune disease segment accounted for the fastest-growing market share during the forecast duration. Even now for vaccine testing immunofluorescence assay is being used for testing the immune system and production of antibodies among patients.
Based on the end-user analysis, the market is bifurcated into medical research organizations, hospitals, pharma & biotech companies, academic and research institutes, and diagnostics centers among others. According to this segment, pharmaceutical &biotechnology companies hold the largest revenue share. This is contributed due to the hike in research and development using immunofluorescence. Research and development using immunofluorescence are being promoted through government schemes in varied countries. Immunofluorescence was highly effective while testing corona antigens in patients throughout the world. During the covid 19 pandemic, the usage of Kits and antigen testing had suddenly risen, especially in hospitals and Diagnostic Centers all over the world. This is contributed due to the pouring number of patients all over the world, who required antigen testing done.
The regional analysis is mainly dominated by North America followed by Europe, Latin America, and Asia-Pacific. This is contributed due to the rise in chronic illness, push by various governments and schemes for investment in research and development, and the cluster of major companies in the area. Asia Pacific countries due to their growing population and increasing aging population density are more prone to chronic illnesses such as cancer, cardiovascular disease, autoimmune disease, etccausing a growing market for immunofluorescence in the region during the forecasted duration. Along with this, every country has seen a hype in coronavirus testing and vaccine production, which in turn has increased the demand for the product market all over the world.
Various competitors in the Immunofluorescence market include Abcam plc, Werfen Company, Bio-Rad Laboratories, Inc, MaxVision Biosciences Inc, AESKU GROUP GmbH, Merck KGaA (Germany), Elabscience, Inc., EpiGentek Group, Cell Signaling Technology, Inc. (US), Abnova Corporation, MEDIPAN GmbH (Germany), J. Mitra& Co. Pvt. Ltd. (India), Sino Biological, Inc. (China), Cellabs (Australia), Danaher Corporation (US), Zyagen, Inc. (US), Agilent Technologies, Enzo Biochem, Inc. (US), Bruker Corporation, Becton, Dickinson, and Company (US), Thermo Fisher Scientific, Inc, Nikon Corporation, Olympus Corporation and PerkinElmer Incamongst others.
Please note: This is not an exhaustive list of companies profiled in the report.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Immunofluorescence Assay Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Immunofluorescence Assay Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
